These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 4576316)

  • 1. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological classification and typing of Clostridium botulinum.
    Giménez DF
    Dev Biol Stand; 1976; 32():175-83. PubMed ID: 793913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serological study of Clostridium botulinum type A and strain 84 toxins].
    Ciccarelli AS; Giménez DF
    Rev Latinoam Microbiol; 1971; 13(2):67-74. PubMed ID: 4941891
    [No Abstract]   [Full Text] [Related]  

  • 6. The toxic antigenic factors produced by Clostridium botulinum types C and D.
    Jansen BC
    Onderstepoort J Vet Res; 1971 Jun; 38(2):93-8. PubMed ID: 4950122
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First outbreak of botulism caused by Clostridium botulinum subtype Af].
    Fernández RA; Ciccarelli AS; Arenas GN; Giménez DF
    Rev Argent Microbiol; 1986; 18(1):29-31. PubMed ID: 3317514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Another type of Clostridium botulinum.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig; 1970; 215(2):221-4. PubMed ID: 4922309
    [No Abstract]   [Full Text] [Related]  

  • 14. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological heterogeneity of Clostridium botulinum type B toxins.
    Shimizu T; Kondo H; Sakaguchi G
    Jpn J Med Sci Biol; 1974 Apr; 27(2):99-100. PubMed ID: 4134872
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on strain 84 of Clostridium botulinum.
    Giménez DF; Ciccarelli AS
    Zentralbl Bakteriol Orig; 1970; 215(2):212-20. PubMed ID: 4992024
    [No Abstract]   [Full Text] [Related]  

  • 17. Noncorrelation between mouse toxicity and serologically assayed toxin in Clostridium botulinum type A culture fluids.
    Betley MJ; Sugiyama H
    Appl Environ Microbiol; 1979 Aug; 38(2):297-300. PubMed ID: 391153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies of type F Clostridium botulinum. IV. Serological properties of soluble and insoluble antigens].
    Rymkiewicz D
    Med Dosw Mikrobiol; 1970; 22(1):13-20. PubMed ID: 4986009
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insoluble antigens in the identification of Cl. botulinum. II. Agglutination and hemagglutination studies and complement fixation reaction].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):47-64. PubMed ID: 4132768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.